7.64
price down icon3.54%   -0.28
after-market Dopo l'orario di chiusura: 7.13 -0.51 -6.68%
loading
Precedente Chiudi:
$7.92
Aprire:
$7.43
Volume 24 ore:
6,881
Relative Volume:
0.47
Capitalizzazione di mercato:
$3.91M
Reddito:
-
Utile/perdita netta:
$-8.26M
Rapporto P/E:
-0.1425
EPS:
-53.609
Flusso di cassa netto:
$-12.17M
1 W Prestazione:
+9.30%
1M Prestazione:
-28.64%
6M Prestazione:
-11.10%
1 anno Prestazione:
-95.78%
Intervallo 1D:
Value
$7.30
$7.96
Intervallo di 1 settimana:
Value
$6.53
$10.95
Portata 52W:
Value
$5.1255
$202.22

Gri Bio Inc Stock (GRI) Company Profile

Name
Nome
Gri Bio Inc
Name
Telefono
(619) 400-1171
Name
Indirizzo
2223 AVENIDA DE LA PLAYA, LA JOLLA
Name
Dipendente
4
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
GRI's Discussions on Twitter

Confronta GRI con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
GRI
Gri Bio Inc
7.64 3.91M 0 -8.26M -12.17M -53.61
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
483.31 124.35B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
684.87 75.07B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
622.61 37.96B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
243.53 31.79B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
BNTX
Biontech Se Adr
111.56 27.34B 3.30B -501.07M 1.03B -2.1146

Gri Bio Inc Stock (GRI) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-09 Iniziato H.C. Wainwright Buy

Gri Bio Inc Borsa (GRI) Ultime notizie

pulisher
Feb 25, 2025

Stock market today: Wah Fu Education Group +219.55%, Jet.AI +46.26% among top gainers in early trading - Business Upturn

Feb 25, 2025
pulisher
Feb 21, 2025

GRI Bio announces 1-for-17 reverse stock split to regain Nasdaq compliance - MSN

Feb 21, 2025
pulisher
Feb 20, 2025

GRI Bio Stock Set to Reverse Split on Monday, February 24th (NASDAQ:GRI) - Defense World

Feb 20, 2025
pulisher
Feb 19, 2025

GRI Bio Announces Reverse Stock Split - GlobeNewswire

Feb 19, 2025
pulisher
Feb 19, 2025

Can GRI Bio's 17:1 Reverse Split Save Its Nasdaq Listing? Key Details Revealed - StockTitan

Feb 19, 2025
pulisher
Feb 19, 2025

GRI Bio, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference - GlobeNewswire

Feb 19, 2025
pulisher
Feb 19, 2025

Vstock Transfer Announces Sponsorship of the Centri Capital Conference at Nasdaq - The Manila Times

Feb 19, 2025
pulisher
Feb 19, 2025

Virtual Investor “Top 5 for ’25” Conference Hosted by JTC Now Available On-Demand - The State

Feb 19, 2025
pulisher
Feb 19, 2025

GRI Bio, Inc. Highlights Key Investment Reasons at Virtual Investor Conference - Nasdaq

Feb 19, 2025
pulisher
Feb 19, 2025

Inside GRI Bio's Ambitious NKT Cell Strategy: Can This Biotech Reshape Inflammatory Disease Treatment? - StockTitan

Feb 19, 2025
pulisher
Feb 13, 2025

GRI Bio approves reverse stock split, stockholders vote in favor - MSN

Feb 13, 2025
pulisher
Feb 12, 2025

MediWound stock climbs 4% on Phase 3 study initiation - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

GMR agree deal for Southern Brave to conclude Hundred sell-off - MSN

Feb 12, 2025
pulisher
Feb 11, 2025

GRI Bio approves reverse stock split, stockholders vote in favor By Investing.com - Investing.com Australia

Feb 11, 2025
pulisher
Feb 07, 2025

Cargill to take full control of Brazil's SJC Bioenergia - MSN

Feb 07, 2025
pulisher
Feb 05, 2025

Analyzing the Price-to-Earnings Ratio of GRI Bio Inc (GRI) - The News Heater

Feb 05, 2025
pulisher
Feb 04, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Feb 04, 2025
pulisher
Feb 03, 2025

BriaCell Therapeutics stock rises on positive clinical trial results - MSN

Feb 03, 2025
pulisher
Feb 02, 2025

Phibro Animal Health (NASDAQ:PAHC) and GRI Bio (NASDAQ:GRI) Critical Review - Defense World

Feb 02, 2025
pulisher
Jan 28, 2025

Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust - GlobeNewswire

Jan 28, 2025
pulisher
Jan 22, 2025

SRIVARU Holding faces trading suspension after nasdaq delisting determination - MSN

Jan 22, 2025
pulisher
Jan 20, 2025

JTC Team Announces Participating Company Line-Up for the Virtual Investor Pitch Conference on June 17-18, 2024 - ACCESS Newswire

Jan 20, 2025
pulisher
Jan 20, 2025

IN8bio Inc (NASDAQ: INAB): What’s Next After The Stock Plunge? - Stocks Register

Jan 20, 2025
pulisher
Jan 20, 2025

Windtree Therapeutics Appoints Leanne Kelly to Board of Directors and Audit Committee - Defense World

Jan 20, 2025
pulisher
Jan 17, 2025

Windtree Therapeutics Appoints Leanne Kelly to Board, Advances New Growth Strategy - MyChesCo

Jan 17, 2025
pulisher
Jan 13, 2025

Windtree Announces the Addition of Leanne Kelly to Its Board of Directors - The Manila Times

Jan 13, 2025
pulisher
Jan 13, 2025

Windtree Therapeutics Strengthens Board with Biotech Finance Veteran Leanne Kelly - StockTitan

Jan 13, 2025
pulisher
Jan 12, 2025

Pre-market Movers: ONCO, EYEN, SGMO, VSTM... - RTTNews

Jan 12, 2025
pulisher
Jan 11, 2025

Pre-market Movers: HSDT, PBM, MTEM, APTO... - RTTNews

Jan 11, 2025
pulisher
Jan 09, 2025

The GRI Marketing Group Joins SDL to Accelerate North America CX Growth Strategy - Yahoo Finance

Jan 09, 2025
pulisher
Dec 29, 2024

Short Interest in GRI Bio, Inc. (NASDAQ:GRI) Increases By 155.5% - Defense World

Dec 29, 2024
pulisher
Dec 29, 2024

FLYHT Aerospace Solutions Ltd. (OTCMKTS:FLYLF) Sees Significant Growth in Short Interest - Defense World

Dec 29, 2024
pulisher
Dec 27, 2024

Viracta stock falls on strategic review (VIRX:NASDAQ) - Seeking Alpha

Dec 27, 2024
pulisher
Dec 23, 2024

GRI Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent Covering GRI-0803 and - EIN News

Dec 23, 2024
pulisher
Dec 23, 2024

GRI Bio Announces European Patent Office Issued a Decision - GlobeNewswire

Dec 23, 2024
pulisher
Dec 23, 2024

GRI Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent Covering GRI-0803 and Its Library of 500+ Proprietary Compounds - GlobeNewswire Inc.

Dec 23, 2024
pulisher
Dec 19, 2024

Mainz Biomed stock higher on Quest deal (MYNZ:NASDAQ) - Seeking Alpha

Dec 19, 2024
pulisher
Dec 10, 2024

GRI Bio (NASDAQ:GRI) Now Covered by HC Wainwright - Defense World

Dec 10, 2024
pulisher
Dec 09, 2024

GRI Bio Inc (NASDAQ: GRI): What’s Next After The Stock Plunge? - Stocks Register

Dec 09, 2024
pulisher
Dec 09, 2024

Astera Labs Inc: Is ALAB Stock Worth Buying? - Stocks Register

Dec 09, 2024
pulisher
Dec 09, 2024

Pre-market Movers: SXTC, STIM, BIOA, UPC... - RTTNews

Dec 09, 2024
pulisher
Dec 06, 2024

GRI Bio to Participate in the Virtual Investor Closing Bell Series - GlobeNewswire

Dec 06, 2024
pulisher
Dec 06, 2024

GRI Bio to Present Corporate Strategy at Virtual Investor Closing Bell Series - StockTitan

Dec 06, 2024
pulisher
Nov 21, 2024

GRI Bio reports progress in IPF treatment with GRI-0621 - Investing.com India

Nov 21, 2024
pulisher
Nov 21, 2024

GRI Bio Showcases GRI-0621’s Potential to Reduce - GlobeNewswire

Nov 21, 2024
pulisher
Nov 21, 2024

GRI Bio's IPF Drug Shows Promise in Preclinical Data, Phase 2a Trial Underway | GRI Stock News - StockTitan

Nov 21, 2024
pulisher
Nov 20, 2024

GRI Bio files to sell 1.58M shares of common stock for holders - MSN

Nov 20, 2024
pulisher
Nov 15, 2024

SEC Form 424B3 filed by GRI Bio Inc. - Quantisnow

Nov 15, 2024
pulisher
Nov 15, 2024

GRI Bio Inc (GRI) Quarterly 10-Q Report - Quartzy

Nov 15, 2024
pulisher
Nov 14, 2024

GRI Bio Reports Third Quarter 2024 Financial Results and Outlines Progress Towards Clinical Data Readout of GRI-0621 in Ongoing Phase 2a Study for Idiopathic Pulmonary Fibrosis - GlobeNewswire

Nov 14, 2024
pulisher
Nov 14, 2024

GRI Bio Raises $13.9M, Extends Runway for Key IPF Drug Trial Data in 2025 | GRI Stock News - StockTitan

Nov 14, 2024

Gri Bio Inc Azioni (GRI) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$76.29
price down icon 6.45%
$22.96
price up icon 1.23%
$33.86
price up icon 0.65%
$19.13
price down icon 7.54%
biotechnology ONC
$245.53
price down icon 9.67%
$111.56
price down icon 1.20%
Capitalizzazione:     |  Volume (24 ore):